Influence of aminoglutethimide on plasma levels of estrone sulphate and dehydroepiandrosterone sulphate in postmenopausal breast cancer patients

The Journal of Steroid Biochemistry and Molecular Biology
J GeislerP E Lønning

Abstract

The aromatase inhibitor aminoglutethimide (AG) is widely used in the treatment of advanced breast cancer in postmenopausal women. Apart from the inhibition of estrogen synthesis, previous studies by our group have shown that AG selectively enhances plasma clearance of the estrogen conjugate estrone sulphate (E1S). In the present study we used a novel, highly sensitive radioimmunoassay to measure plasma E1S during treatment with AG. Treatment with AG decreased plasma levels of E1S from a mean pretreatment value of 372.4 to 50.6 pmol/l (mean suppression to 14.5% of pretreatment values) whereas plasma levels of E1 and E2 were suppressed to 40.7 and 32.8% of pretreatment values, respectively. Dehydroepiandrosterone sulphate levels decreased from a mean value of 0.8 to 0.5 micromol/l (mean suppression to 59.6% of pretreatment values), whereas the ratios of E1S/E1 and DHEAS/DHEA decreased to 30.8% (P < 0.001) and 55.5% (P < 0.005) of pretreatment values, respectively. In conclusion, we found that AG suppressed plasma levels of E1S more extensively compared to previous studies. The simultaneous suppression of the DHEAS/DHEA ratio suggests that AG may influence the disposition of steroid sulphates in general.

References

Dec 1, 1978·The Journal of Clinical Endocrinology and Metabolism·R J SantenE Ruby
Jan 1, 1979·Pharmacology & Therapeutics·H M Bolt
Oct 1, 1975·Clinical Pharmacology and Therapeutics·G R Wilkinson, D G Shand
Jan 1, 1992·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A L JonesT J Powles
May 1, 1991·British Journal of Cancer·P E LønningM Dowsett
Aug 31, 1989·Biochimica Et Biophysica Acta·J KawanoE Aikawa
Oct 1, 1989·Journal of Steroid Biochemistry·P E LønningD Ekse
Dec 11, 1986·The New England Journal of Medicine·E Barrett-ConnorS S Yen
Feb 1, 1973·The Journal of Clinical Endocrinology and Metabolism·J M GrodinP C MacDonald
Apr 1, 1974·The Journal of Clinical Endocrinology and Metabolism·C Longcope, K I Williams
Jan 1, 1972·The Journal of Clinical Endocrinology and Metabolism·C Longcope
May 1, 1983·British Journal of Cancer·A L HarrisS L Jeffcoate
Dec 1, 1983·Clinical Endocrinology·A VermeulenJ C Heuson
Jul 1, 1984·The Journal of Clinical Endocrinology and Metabolism·S J SantnerR J Santen
Sep 27, 1995·International Journal of Cancer. Journal International Du Cancer·A PurohitM J Reed
Dec 1, 1995·The Journal of Steroid Biochemistry and Molecular Biology·P E Lønning, D Ekse
Nov 1, 1995·Critical Reviews in Oncology/hematology·E Lønning, E A Lien

❮ Previous
Next ❯

Citations

Nov 15, 2011·Breast Cancer Research and Treatment·Michaela J HigginsVered Stearns
Feb 18, 2004·Clinica Chimica Acta; International Journal of Clinical Chemistry·Wattana Leowattana
Sep 27, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Y F LiJ J Kavanagh
Feb 28, 2002·Journal of Clinical Pharmacology·Firoozeh S SalekPatricia Dowley Kroboth
Jun 1, 2002·Drugs & Aging·Per E Lønning
May 18, 2000·Cancer Treatment Reviews·E A Lien, P E Lønning
Feb 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jürgen GeislerPer Eystein Lønning
Mar 20, 2002·Clinical Breast Cancer·J Geisler, P E Lønning
Apr 20, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jürgen Geisler, Per Eystein Lønning

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.